Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe/simvastatin versus atorvastatin or rosuvastatin in high-risk patients not at LDL-C goal on simvastatin 40 mg
2006-006219-56Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypercholesterolemia comparing Ezetimibe + simvastatin arm, Atorvastatin arm and Rosuvastatin arm (3 arms). Primary endpoint: Proportion of patients achieving fasting LDL-C target. Started Feb 2007; status: completed.
02
Drugs
ezetimibesimvastatinatorvastatinrosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on 2006-006219-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006219-56.